DE60323332D1 - Verfahren und zusammensetzungen zur behandlung der männlichen erektionsstörung - Google Patents

Verfahren und zusammensetzungen zur behandlung der männlichen erektionsstörung

Info

Publication number
DE60323332D1
DE60323332D1 DE60323332T DE60323332T DE60323332D1 DE 60323332 D1 DE60323332 D1 DE 60323332D1 DE 60323332 T DE60323332 T DE 60323332T DE 60323332 T DE60323332 T DE 60323332T DE 60323332 D1 DE60323332 D1 DE 60323332D1
Authority
DE
Germany
Prior art keywords
compositions
male
treating male
malfunction
effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60323332T
Other languages
English (en)
Inventor
Ramsey Sallis
Quoc Huan Ha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Modular Properties Ltd
Original Assignee
Modular Properties Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modular Properties Ltd filed Critical Modular Properties Ltd
Application granted granted Critical
Publication of DE60323332D1 publication Critical patent/DE60323332D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60323332T 2002-01-25 2003-01-24 Verfahren und zusammensetzungen zur behandlung der männlichen erektionsstörung Expired - Lifetime DE60323332D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35163402P 2002-01-25 2002-01-25
PCT/US2003/002082 WO2003063776A2 (en) 2002-01-25 2003-01-24 Methods and compositions for treating male erectile dysfunction

Publications (1)

Publication Number Publication Date
DE60323332D1 true DE60323332D1 (de) 2008-10-16

Family

ID=27663012

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60323332T Expired - Lifetime DE60323332D1 (de) 2002-01-25 2003-01-24 Verfahren und zusammensetzungen zur behandlung der männlichen erektionsstörung

Country Status (9)

Country Link
US (1) US7405222B2 (de)
EP (1) EP1474143B1 (de)
AT (1) ATE406900T1 (de)
AU (1) AU2003209350A1 (de)
CY (1) CY1108631T1 (de)
DE (1) DE60323332D1 (de)
DK (1) DK1474143T3 (de)
PT (1) PT1474143E (de)
WO (1) WO2003063776A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090257956A1 (en) * 2002-01-25 2009-10-15 Ramsey Sallis Treatment Method for Treatment of Erectile Dysfunction and Premature Ejaculation
US20090035221A1 (en) * 2002-01-25 2009-02-05 Ramsey Sallis Methods and Compositions for Treatment of Erectile Dysfunction
US8287474B1 (en) 2002-08-22 2012-10-16 Koenig J Frank Method and apparatus for noninvasively increasing whole body blood flow and noninvasive physical exercise of limbs from the outside and from within the limb to treat diseases throughout the body
KR101086147B1 (ko) 2003-03-21 2011-11-25 넥스메드 홀딩스 인코포레이티드 조루증 치료용 조성물 및 치료 방법
DE102006022554B4 (de) * 2006-05-15 2014-12-04 Roche Diagnostics Gmbh Verfahren und Vorrichtung zum Stimulieren eines Gewebes für die subkutane Verabreichung von Wirkstoffen
US7718595B2 (en) * 2008-06-17 2010-05-18 Colgate Palmolive Company Light duty liquid cleaning compositions and methods of manufacture and use thereof comprising organic acids
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
US9192613B1 (en) 2014-10-14 2015-11-24 Sapere Ip, Llc Treatment method for primary premature ejaculation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127118B1 (en) 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
GB9423910D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6127363A (en) * 1997-10-28 2000-10-03 Vivus, Inc. Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
GB9823102D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
US6303135B1 (en) 1999-07-08 2001-10-16 Neal R. Cutler Use of quinolines and quinolones to treat male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction

Also Published As

Publication number Publication date
EP1474143B1 (de) 2008-09-03
US20030144318A1 (en) 2003-07-31
DK1474143T3 (da) 2009-01-26
WO2003063776A3 (en) 2003-10-23
ATE406900T1 (de) 2008-09-15
WO2003063776A2 (en) 2003-08-07
EP1474143A4 (de) 2005-05-11
EP1474143A2 (de) 2004-11-10
US7405222B2 (en) 2008-07-29
PT1474143E (pt) 2009-01-02
AU2003209350A1 (en) 2003-09-02
CY1108631T1 (el) 2014-04-09

Similar Documents

Publication Publication Date Title
CY1108631T1 (el) Μεθοδοι και συνθεσεις για τη θεραπεια στυτικης δυσλειτουργιας των ανδρων
DE60335743D1 (de) Verbindungen und verfahren zur erhöhung der neurogenese
ATE517638T1 (de) Verfahren und zubereitungen zum verabreichen von therapeutischen und diagnostischen mitteln
ATE434625T1 (de) Verfahren zur schmerzbehandlung durch verabreichung eines antagonistischen antikörpers gegen den nervenwachstumfaktor und eines opioid- analgetikums sowie diese enthaltende zusammensetzungen
ATE464323T1 (de) Zusammensetzungen und verfahren für die tumor- diagnose und behandlung
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
ATE497391T1 (de) Verfahren zur behandlung von postoperativen schmerzen durch verabreichung eines antikörpers gegen nervenwachstumsfaktor und diesen enthaltende zusammensetzungen
HUP0400659A2 (hu) Kitinázokkal, kitinázszerű molekulákkal és gyulladásos megbetegedéssel kapcsolatos eljárások, készítmények és reagenskészletek
CY1107478T1 (el) Η χρηση της τραμαδολης για καθυστερηση της εκσπepματισης
EA199700213A1 (ru) Крем на водной основе для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений
ATE478062T1 (de) Zusammensetzungen und verfahren zur in vivo abbildung von loeslichen beta-amyloid
ATE329587T1 (de) Zusammensetzungen zur verwendung bei der behandlung der osteoporose und/oder der entzündlichen gelenkerkrankungen
ATE550015T1 (de) Verfahren und zusammensetzung zur behandlung von rhinitis
RU2006143652A (ru) Фармацевтические композиции и их применение в лечении женской сексуальной дисфункции
ATE424816T1 (de) Zubereitungen für die topische anwendung und verfahren zur abgabe eines wirkstoffs an ein substrat
DE69822295D1 (de) Verwendung von misoprostol und/oder misoprostolsäure zur behandlung von erektionsstörungen
DE602006009786D1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
ATE478672T1 (de) Methode zur behandlung sexueller fehlfunktionen
NO20055390L (no) Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
DE60232244D1 (de) Nachweis und behandlung von prostatakrebs
MXPA04011835A (es) Tratamiento de combinacion para la depresion y ansiedad.
BR0307345A (pt) Métodos para tratar disfunção erétil, para melhorar a microcirculação da glans penis e para produzir intumescência da glans penis em um paciente necessitando de tais tratamentos, artigo de manufatura, e, composição
DE602005027228D1 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind
WO2002053143A3 (en) Treatment of erectile dysfunction with rho-kinase inhibitors
EP1930009A3 (de) Verfahren und Zusammensetzungen zur Behandlung der männlichen erektilen Dysfunktion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition